ASCENDIS PHARMA A/S -
130.89
26-十一月-24 09:59:22
15 分钟延时
股票
+0.04
+0.03%
今日范围
128.63 - 131.42
ISIN
N/A
来源
NASDAQ
-
Ascendis Pharma Reports Third Quarter 2024 Financial Results
14 11月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
07 11月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
04 11月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
30 9月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
30 9月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
19 9月 2024 20:16:32 条件 Nasdaq GlobeNewswire
-
Ascendis Pharma A/S Announces Proposed Public Offering of ADSs
18 9月 2024 16:04:11 条件 Nasdaq GlobeNewswire
-
16 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
13 9月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
11 9月 2024 17:37:50 条件 Nasdaq GlobeNewswire
-
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
03 9月 2024 17:06:29 条件 Nasdaq GlobeNewswire
-
Ascendis Pharma Reports Second Quarter 2024 Financial Results
03 9月 2024 17:04:32 条件 Nasdaq GlobeNewswire
-
28 8月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
12 8月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
24 6月 2024 16:45:36 条件 Nasdaq GlobeNewswire
-
Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
04 6月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
Ascendis Pharma Presents New Data and Updated Results from Phase 1/2 IL-Believe Trial at ASCO 2024
03 6月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
Ascendis to Spotlight Latest Updates for TransCon™ Rare Endocrinology Disease Portfolio at ENDO 2024
30 5月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
14 5月 2024 14:31:44 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >